Table 3 Status of oral corticosteroid use

Yes^*

36

(43.9)

Oral corticosteroids were used at the start of treatment with abatacept

36

(100.0)

Oral corticosteroids were not discontinued during treatment with abatacept

21

(58.3)

Oral corticosteroid doses were ultimately increased during treatment with abatacept

4

(11.1)

Oral corticosteroid doses were not changed during treatment with abatacept

11

(30.6)

Oral corticosteroid doses were ultimately reduced during treatment with abatacept

6

(16.7)

Oral corticosteroids were discontinued during treatment with abatacept

14

(38.9)

Oral corticosteroids were discontinued due to an adverse event

0

(0.0)

Unknown whether oral corticosteroids were discontinued during the treatment period

1

(2.8)

Treatment with oral corticosteroids was started during treatment with abatacept

0

(0.0)